Philip Kantoff

Philip Kantoff Philip W. Kantoff is a medical oncologist. He is the chairman and chief executive officer (CEO) of Convergent Therapeutics. He served as the Chairman of Medicine at Memorial Sloan Kettering Cancer Center between 2015 and 2021. He is best known for his contributions to the impact of DNA abnormalities in prostate cancer and the discovery of therapies for metastatic hormone-sensitive prostate cancer. Provided by Wikipedia
Showing 1 - 1 results of 1 for search 'Philip W. Kantoff', query time: 0.01s Refine Results
  1. 1
    Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer

    Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer by Lior Z. Braunstein, Ming-Hui Chen, Marian Loffredo, Philip W. Kantoff, Anthony V. D'Amico

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: